ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 418

Dose-Response Relationship between Neuromuscular Electrical Stimulation and Muscle Function in Patients with Rheumatoid Arthritis

Gustavo J. Almeida1, Samannaaz S. Khoja2 and Sara R. Piva1, 1Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 2Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: exercise, muscle biopsy, Muscle strength, physical function and physical therapy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Orthopedics, Low Back Pain and Rehabilitation Poster – ACR/ARHP

Session Type: ACR/ARHP Combined Abstract Session

Session Time: 9:00AM-11:00AM

Background/Purpose: Neuromuscular electrical stimulation (NMES) is a viable intervention to improve impaired muscle function of patients with rheumatoid arthritis (RA). However, there is limited evidence about dose-response of NMES to promote muscle function in these patients. The purpose of this study was to investigate the dose-response relationship between NMES and muscle function in patients with RA and to establish the minimal NMES intensity to promote improvements.

Methods: This was a secondary analysis of pre to post NMES intervention from a randomized study. Participants were adults diagnosed with RA. Participants underwent 36 NMES treatment sessions for the quadriceps muscles over 16 weeks. Muscle function was assessed pre- and post-intervention by the following 3 measures: quadriceps cross-sectional area and muscle quality were quantified using computed tomography, and strength via an isokinetic dynamometer. NMES intensity was calculated in percentage dividing NMES-elicited quadriceps muscle torque by maximum voluntary isometric contraction (MVIC). Improvements in muscle function were calculated using paired samples t-test. Dose-response relationship was determined using curve estimation regression statistics. The minimum NMES intensity was defined as the one sufficient to significantly improve all muscle function measures.

Results: Twenty-four subjects (48 legs) participated (75% female, 58[8] years old, and BMI of 32[7] kg/m2). Quadriceps cross-sectional area, muscle quality and strength improved pre-post intervention (p<.001) (Table 1). Associations between NMES and muscle quality (r2=0.20) and strength (r2=0.23) were significant, but between NMES and muscle cross-sectional area was not (r2=0.02). The minimum NMES intensity necessary to improve all measures of muscle function ranged from 11% to 20% of MVIC (Table 2).

Conclusion: The minimum NMES intensity for significant gains in muscle function is around 15%. Larger NMES intensities may promote better muscle quality and strength in patients with RA.

Table 1: Muscle function pre and post NMES.

Variables

Baseline

Follow-up

Change

95% CI of Change

Quadriceps Cross-sectional Area (cm2)

48.8 (8.5)

52.4 (8.5)

3.6 (2.8)

2.8; 4.4

Quadriceps muscle quality (HU)

45.9 (4.6)

47.4 (5.1)

1.5 (2.3)

0.8; 2.2

Quadriceps Strength (Nm)

144.6 (33.9)

158.6 (36.3)

14.1 (19.8)

8.3; 19.9

Table 2: NMES dose-response of quadriceps muscle function outcomes.

Intensity

(% MVIC)

Muscle Cross-sectional Area

Muscle Quality

Muscle Strength

Change in cm2

95% CI

Change in HU

95% CI

Change in Nm

95% CI

1 to 10 (n=8)

3.23

1.85; 4.61

0.15

-0.89; 1.18

1.16

-7.60; 9.91

11 to 20 (n=7)

3.43

2.40; 4.45

1.18

0.42; 1.95

11.08

4.60; 17.57

21 to 30 (n=13)

3.59

2.45; 4.74

1.87

1.01; 2.73

17.63

10.37; 24.89

31 to 40 (n=6)

3.80

2.61; 4.99

2.40

1.51; 3.29

22.56

15.01; 30.12

41 to 50 (n=4)

3.98

2.76; 5.19

2.58

1.67; 3.49

24.12

16.41; 31.83

51 to 60 (n=10)

4.15

2.34; 5.96

2.48

1.12; 3.84

22.89

11.39; 34.38


Disclosure: G. J. Almeida, None; S. S. Khoja, None; S. R. Piva, None.

To cite this abstract in AMA style:

Almeida GJ, Khoja SS, Piva SR. Dose-Response Relationship between Neuromuscular Electrical Stimulation and Muscle Function in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/dose-response-relationship-between-neuromuscular-electrical-stimulation-and-muscle-function-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dose-response-relationship-between-neuromuscular-electrical-stimulation-and-muscle-function-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology